Related Experiment Video
Updated: Feb 27, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
Group B Streptococcal Disease
Karen M Puopolo1,2,3
1University of Pennsylvania Perelman School of Medicine, Philadelphia.
Insights
Group B Streptococcus (GBS) causes invasive infections in newborns. Vaccines are in development to prevent GBS disease in all at-risk populations, including infants and adults.
Area of Science:
- Bacteriology
- Immunology
- Vaccinology
Background:
- Group B Streptococcus (GBS) is a common colonizer of the gastrointestinal and genitourinary tracts.
- GBS is the leading bacterial cause of invasive infections in U.S. newborns.
- Current prevention strategies like intrapartum antibiotic prophylaxis are limited to pregnant individuals and newborns.
Purpose of the Study:
- To review the current landscape of Group B Streptococcus (GBS) disease.
- To highlight the unmet need for prevention strategies beyond the neonatal period.
- To discuss the potential of GBS vaccines for broader population protection.
Main Methods:
- Literature review of GBS epidemiology and prevention strategies.
- Analysis of current vaccine development approaches for GBS.
- Assessment of GBS vaccine candidates targeting capsular polysaccharides conjugated to protein antigens.
Main Results:
- GBS remains a significant threat to newborns, with limited prevention options for later infancy and nonpregnant adults.
- Vaccines composed of GBS capsular polysaccharides conjugated to protein carriers are under development.
- These novel vaccines show promise for preventing GBS disease across diverse at-risk groups.
Conclusions:
- There is a critical need for GBS prevention strategies applicable to all age groups.
- Developing GBS vaccines is a promising approach to address this public health challenge.
- GBS vaccines may offer a comprehensive solution for preventing invasive GBS disease in vulnerable populations.
Abstract:
Group B streptococcus commonly colonizes the human gastrointestinal and genitourinary tracts and is the single most common bacterial cause of invasive infection among newborns in the United States. Intrapartum antibiotic prophylaxis is currently used to reduce the risk of group B streptococcal disease among pregnant persons and newborns. No strategies are currently available to prevent disease in later infancy or among nonpregnant adults. Vaccines against group B streptococcal disease that consist of capsular polysaccharides linked to protein antigens are in development and may provide a means of prevention for all at-risk populations.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management
Bacterial Phylum Spirochaetes
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Bacterial Phylum Proteobacteria
Endocarditis I: Introduction

